glaxosmithkline

U.S. stocks rose for the fourth-consecutive day as investors found plenty of positives in today's ADP National Employment Report released today. As a result, the S&P 500 hit new all time highs of 1,893.17 while the Dow remains just a few small points away from its all time highs. The next...

U.S. stocks recovered most of Wednesday's losses after Fed Chief Janet Yellen spooked the markets a bit by hinting a rate hike could occur as soon as six months after the central bank terminates its quantitative-easing program. Investors found positives in several economic reports released...

U.S. stocks closed the day slightly lower as investors digested news that China's exports dropped significantly. Philadelphia Fed Chief Charles Plosser said in a speech today that February's harsh winter likely curbed jobs growth in the month. Plosser's remarks echo similar sentiments by other...

The new year has proved to be a volatile one on the stock markets. After seeing a sizable correction in January, the S&P 500 and Dow Jones Industrial Average (DJIA) are again hitting or near all-time highs. Here is a quick look at the five top-performing Dow stocks in the past month. Note...

Pullbacks and sell-offs provide a perfect opportunity for investors who have faith in a company to snap up shares. Here are some stocks that have seen insider buying recently. Aircastle Japanese trading company Marubeni Corp. has been scooping up batches of Aircastle (NYSE: AYR) shares since last...

U.S. stocks overcame mixed economic data and earning reports as the S&P 500 inches towards new all time highs and the Dow recorded an almost triple digit point gain. Jobless claims declined less than expected while consumer prices met expectations and rose slightly. Data from the...

U.S. stocks continued its losses on an accelerated basis on Monday. Investors are in clear panic mode following a report that U.S manufacturing activity expanded at a slower pace in January. The Dow plunged more than 300 points while the S&P 500 and Nasdaq both fell more than two percent as...

Among leading biotech and emerging pharmaceutical companies, the number of shares sold short in Amgen (NASDAQ: AMGN), Gilead Sciences (NASDAQ: GILD) and Pharmacyclics (NASDAQ: PCYC) grew by the largest percentages between the November 29 and December 13 settlement dates. Medivation saw its short...

Among leading biotech and emerging pharmaceutical companies, the number of shares sold short in Alexion Pharmaceuticals (NASDAQ: ALXN), BioMarin Pharmaceutical (NASDAQ: BMRN) and Gilead Sciences (NASDAQ: GILD) grew by the largest percentages in late October. Biogen Idec (NASDAQ: BIIB), Illumina...

Apple (NASDAQ: AAPL), CBS (NYSE: CBS), Merck (NYSE: MRK) and Wal-Mart (NYSE: WMT) all have or are expected to have monster stock repurchase plans of more than $5 billion. Below, we take a quick look at how these stocks have fared and what analysts expect from them. When it comes to returning...

Among biotech and emerging pharmaceutical companies, Gilead Sciences (NASDAQ: GILD) and Onyx Pharmaceuticals (NASDAQ: ONXX) saw the most significant rises in short interest between the June 14 and June 28 settlement dates. The number of shares sold short in Amgen (NASDAQ: AMGN), Arena...

The short interest in biotech and emerging pharmaceutical companies was mixed again in the first two weeks of March. The number of shares sold short in Arena Pharmaceuticals (NASDAQ: ARNA), Dendreon (NASDAQ: DNDN), Illumina (NASDAQ: ILMN) and VIVUS (NASDAQ: VVUS) grew somewhat between the...

The short interest in biotech and emerging pharmaceutical companies was mixed again in the first two weeks of January. The number of shares sold short in Arena Pharmaceuticals (NASDAQ: ARNA), Dendreon (NASDAQ: DNDN), Gilead Sciences (NASDAQ: GILD), Onyx Pharmaceuticals (NASDAQ: ONXX) and Vertex...

The short interest in biotech and emerging pharmaceutical companies was mixed again in the final two weeks of November. Shares sold short in Alexion Pharmaceuticals (NASDAQ: ALXN), Illumina (NASDAQ: ILMN) and Regeneron Pharmaceuticals (NASDAQ: REGN) grew somewhat between the November 15 and...

Bank of America Merrill Lynch offered some defensive stock picks for 2013 in a research report. Two drug makers and an REIT focused on health care facilities made the list. They were Eli Lilly (NYSE: LLY), Pfizer (NYSE: PFE) and Ventas (NYSE: VTR). Here is a quick look at how these three picks...